课题基金 / 基金详情

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF DIFFERENT DUP-753 (MK954) DOSES

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF DIFFERENT DUP-753 (MK954) DOSES
不同剂量 DUP-753 (MK954) 的抗高血压功效和安全性
批准号：
3788171
负责人：
EDWARD C. CONRADI
金额：
$0.0万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3788171
关键词：
angiotensin II antihypertensive agents dosage drug quality /standard drug screening /evaluation enalapril hormone receptor human subject human therapy evaluation imidazole placebos

项目摘要

项目成果

EDWARD C. CONRADI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to investigate the efficacy, safety and dose-range of DuP 753, an investigational drug, which has been shown to lower blood pressure by inhibiting angiotensin II receptors. This will be done in a double-blind randomized study comparing DuP-753 to placebo or enalapril (currently approved and marketed for hypertension).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISRADIPINE, ENALAPRIL & ATENOLOL EFFECTS ON ELDERLY FEMALE PATIENTS
DILTIAZEM ER DOSE RESPONSE IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
COMPARING EFFICACY AND TOLERABILITY OF FELODIPINE AND VERAPAMIL
ANTIHYPERTENSIVE EFFICACY AND SAFETY OF DIFFERENT DUP-753 (MK954) DOSES
海外基金